Dividend compounder review
ILMN
Illumina Inc · NASDAQ · US
Healthcare · Diagnostics & Research
Score53.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Quality breakdown
Dividend Reliability
0.0 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
17.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
25.0 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
6.0 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
5.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$850.0M
Free Cash Flow$931.0M
FCF Covers DividendUnknown
Debt / Equity0.95
P/E29.3
Revenue Growth 5Y6.0%
Net Margin19.4%
ROE33.8%
Price vs Trend19.6%
3Y Return-17.9%
5Y Return-65.1%
CurrencyUSD
Review flags
No usable dividend history found.
Activity record
No usable dividend history found.